Prognostic significance of del(20q) in patients with hematological malignancies
- 15 July 2005
- journal article
- research article
- Published by Elsevier BV in Cancer Genetics and Cytogenetics
- Vol. 160 (2), 188-192
- https://doi.org/10.1016/j.cancergencyto.2004.12.019
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genesOncogene, 2000
- Refinement of the commonly deleted segment in myeloid leukemias with a del(20q)Genes, Chromosomes and Cancer, 1998
- Characterization of 20q deletions in patients with myeloproliferative disorders or myelodysplastic syndromesCancer Genetics and Cytogenetics, 1995
- Deletion 20q in association with Philadelphia chromosome positive acute lymphoblastic leukemiaCancer Genetics and Cytogenetics, 1995
- Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromesBlood, 1994
- Molecular heterogeneity at the breakpoints of smaller 20q deletionsGenes, Chromosomes and Cancer, 1994
- Cell lineage involvement of recurrent chromosomal abnormalities in hematologic neoplasmsGenes, Chromosomes and Cancer, 1994
- Cytogenetic analysis in the diagnosis of acute leukemiaCancer, 1992
- c-src is consistently conserved in the chromosomal deletion (20q) observed in myeloid disorders.Proceedings of the National Academy of Sciences of the United States of America, 1985
- The Chromosomes in Polycythaemia VeraBritish Journal of Haematology, 1966